ACTIVE

BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY

Financial year 2025 · Closed on 31/12/2025

Net result-462,3 k €-617,0 %over 1 year

Gross margin-482 k €-247,9 %over 1 year

Equity771,7 k €-37,5 %over 1 year

Identity

Source · BCE/KBO

BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY is a Non-profit organization incorporated in 1989. Its main activity is: Other human health activities. Its registered office is in Jette.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0439.302.013
Incorporation: 28/02/1989
Legal form: Non-profit organization
Registered office: Avenue du Laerbeek 101
1090 Jette · BruxellesSee on map
Latest accounts: 31/12/2025

Activities (NACE)

86909Other human health activities· main 86995Other human health activities

Signals

Solid equityLow riskGood liquidity

Financials

Source · NBB, 14 filings

Trend over 14 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	-482 k €	-248%	-138,6 k €	+20.2%	-173,5 k €	-322%	78,3 k €	+20.2%	65,1 k €
EBITDA	-485,3 k €	-241%	-142,1 k €	+18.9%	-175,2 k €	-329%	76,4 k €	+20.7%	63,3 k €
Operating result	-485,4 k €	-241%	-142,1 k €	+19.1%	-175,6 k €	-332%	75,8 k €	+20.8%	62,7 k €
Net result	-462,3 k €	-617%	-64,5 k €	+44.0%	-115,1 k €	-91.4%	-60,1 k €	-150%	121 k €
Balance sheet
Equity	771,7 k €	-37.5%	1,2 M €	-5.0%	1,3 M €	-8.1%	1,4 M €	-4.1%	1,5 M €
Total assets	895,5 k €	-28.8%	1,3 M €	-5.2%	1,3 M €	-9.1%	1,5 M €	-3.0%	1,5 M €
Cash	140,9 k €	-16.8%	169,2 k €	+22.9%	137,7 k €	-58.0%	327,6 k €	+172%	120,4 k €
Debts	123,8 k €	+410%	24,2 k €	-15.7%	28,8 k €	-38.6%	46,8 k €	+49.3%	31,3 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 6 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Daniel Klink	Directorsince 17/06/2025
Elise Nauwynck	Directorsince 17/06/2025
Jean De Schepper	Directorsince 03/05/2011Mandatesince 03/05/2011ended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Marianne Becker	Directorsince 15/05/2020
Philippe Lysy	Directorsince 15/05/2020
Anne-Simone Parent	Director21/02/2017 → 15/05/2020

Other companies at this address

Avenue du Laerbeek 101 1090 Jette

Company	CBE no.
ASSOCIATION BELGE DES CEPHALEES● Active	0426.169.597
ASSOCIATION BELGE D'ETUDES SUR L'OBESITE● Active	0821.426.781
Association belge pour l'Etude du Cancer-Belgische Vereniging voor de Studie van de Kanker● Active	0455.750.144
Belgian Diabetes Registry● Active	0445.480.121
Belgian Knee Society● Active	0878.052.809
belgian society of pediatric gastroenterology hepatology and nutrition● Active	0436.592.545
BELGIAN STROKE COUNCIL● Active	0476.530.613
Belgische Vereniging voor Assistenten in Opleiding in de Plastische, Reconstructieve en Esthetische Chirurgie● Active	0759.491.786
Belgische Vereniging voor Orthopedie en Traumatologie● Active	0411.514.679
Brusselse Vereniging Geneesheren-Assistenten● Liquidation	0451.554.596
Centrum voor ontwikkelingsstoornissen brussel● Active	0459.082.489
FACOS● Active	1018.806.539
Fondation Sanoua● Active	0460.057.043
INTERACTIVEPEDIATRIC INTENSIVE CARE DAY● Active	0467.740.631
Ronald McDonald Kinderfonds België● Active	0740.483.647
RONALD MCDONALD KINDERFONDS - FONDS RONALD MCDONALD POUR LES ENFANTS● Active	0475.833.104
The Toxicological Society of Belgium and Luxembourg● Active	0435.806.944
UZ BRUSSEL PENSIOENFONDS● Active	0445.571.676
Villa Samson vzw● Active	0648.584.362
VLAAMSE DIABETESCENTRA VOOR KINDEREN EN ADOLESCENTEN● Active	0880.750.892

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Micro model	Micro model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	25/06/2026	11/07/2025	18/07/2024	17/07/2023	26/07/2022	28/07/2021
General meeting	19/05/2026	17/06/2025	20/06/2024	30/06/2023	30/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 14 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	19/05/2026	25/06/2026	Dutch	PDF
Abridged model	31/12/2024	17/06/2025	11/07/2025	Dutch	PDF
Abridged model	31/12/2023	20/06/2024	18/07/2024	Dutch	PDF
Micro model	31/12/2022	30/06/2023	17/07/2023	Dutch	PDF
Micro model	31/12/2021	30/06/2022	26/07/2022	Dutch	PDF
Abridged model	31/12/2020	30/06/2021	28/07/2021	Dutch	PDF
Abridged model	31/12/2019	15/05/2020	23/07/2020	Dutch	PDF
Abridged model	31/12/2018	24/05/2019	11/07/2019	Dutch	PDF
Abridged model	31/12/2017	20/03/2018	20/07/2018	Dutch	PDF
Abridged model	31/12/2016	21/02/2017	26/09/2017	Dutch	PDF
Abridged model	31/12/2015	17/05/2016	22/06/2016	Dutch	PDF
Abridged model	31/12/2014	11/05/2015	02/06/2015	Dutch	PDF
Abridged model	31/12/2013	05/05/2014	03/07/2014	Dutch	PDF
Abridged model	31/12/2012	21/05/2013	20/06/2013	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 6 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Daniel Klink	Directorsince 17/06/2025
Elise Nauwynck	Directorsince 17/06/2025
Jean De Schepper	Directorsince 03/05/2011Mandatesince 03/05/2011ended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Marianne Becker	Directorsince 15/05/2020
Philippe Lysy	Directorsince 15/05/2020
Anne-Simone Parent	Director21/02/2017 → 15/05/2020

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates11/09/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates14/11/2023
ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING
PDF
Mandates22/12/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates15/12/2017
ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/09/2014
DEMISSIONS, NOMINATIONS
PDF
Mandates30/09/2014
BENAMING - ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/06/2013
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/06/2013
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings14 filings

Mandates

Elise Nauwynck

Daniel Klink

Philippe Lysy

Marianne Becker

Anne-Simone Parent

Dominique Beckers

Jean De Schepper

Sylvie Tenoutasse

Raoul Rooman

19891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

BELSPEED - Belgian and Luxemburgish Society for Pediatric Endocrinology and DiabetologyBELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY

Avenue du Laerbeek 101, 1090 Jette

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Avenue du Laerbeek 101, 1090 JetteCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00206223

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGYCurrent		CBE
BELSPEED - Belgian and Luxemburgish Society for Pediatric Endocrinology and Diabetology	accounts 2023 → 2025	Accounts 2025 · 2026-00206223
BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY	accounts 2013 → 2022	Accounts 2022 · 2023-00247296
BELGIAN STUDY GROUP FOR PEDIATRIC ENDOCRINOLOGY	accounts 2012	Accounts 2012 · 2013-20000432

Events

2025
Annual accounts 2025-462,3 k €↓
2024
Annual accounts 2024-64,5 k €↑
2023
Annual accounts 2023-115,1 k €↓
2023
Name changeBELSPEED - Belgian and Luxemburgish Society for Pediatric Endocrinology and Diabetology
2022
Annual accounts 2022-60,1 k €↓
2021
Annual accounts 2021121 k €↑
2020
Annual accounts 2020-126,7 k €↓
2019
Annual accounts 2019-94 k €↑
2018
Annual accounts 2018-116,8 k €↓
2017
Annual accounts 2017-12 k €↑
2016
Annual accounts 2016-74 k €↓
2015
Annual accounts 201568,7 k €↓
2014
Annual accounts 2014158,3 k €↑
2013
Annual accounts 2013-43,8 k €↓
2013
Name changeBELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY
2012
Annual accounts 2012125 k €
28/02/1989
IncorporationNon-profit organization

BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events